This may potentially explain why differences between good and poor disease outcome in stage III CRC did not reach statistical significance.
← all excerpts
SPARC, FOXP3, CD8 and CD45 correlation with disease recurrence and long-term disease-free survival in colorectal cancer.
1
—
—